Addictive Potential: Unknown
Emergency Room Visits Yearly: Unknown
Mandatory Minimum Sentence: NA
Mechanism of Action: partial agonist at the 5-HT(1a) receptor; inhibits [3H] 5-HT transport at the SERT and VMAT2
DPT is also known as N,N-dipropyltryptamine, the Light, and N,N-DPT. This close cousin to DMT was first synthesized in the 1950s and tested in animals in the 1960s. According to Wang and Chen (2007), it is a psychedelic tryptamine that “is found either as a crystalline hydrochloride salt or as an oily or crystalline base”.
In the 1970s, it was studied as a possible treatment for alcoholism and in DPT-assisted psychotherapy for terminal cancer patients. Soskin, Grof, and Richards (1973) reported that their research study participants experienced “intensification of emotions, self-exploration at deeper levels of the psyche, recovery of emotionally relevant positive or negative memories, and enhanced insight into personal dynamics”.
In the 1980s, the Temple of the True Inner Light began using DPT as a sacrament. Pauli (1997) explained that “DPT ingestion, according to the Temple, allows direct communication with spirit forms and this communication provides the source of their theology”.
In recent years, DPT has been found on the illicit drug market (DEA, 2005).
Side Effects & Adverse Reactions:
Negative effects that have been reported include:
- Extreme panic and/or fear reactions (Soskin, Grof, & Richards, 1973)
- Muscle tension (Erowid, 2001)
- Seizures (Erowid, 2001)
- Increased heart rate (Erowid, 2001)
- Dizziness (Faillace et al., 1967)
- Numbness and tingling (Faillace et al., 1967)
- Chills and cold feeling (Faillace et al., 1967)
- Nausea (Faillace et al., 1967)
- Blurred vision (Faillace et al., 1967)
- Dry mouth (Faillace et al., 1967)
- Physical weakness (Faillace et al., 1967)
- Body felt light (Faillace et al., 1967)
Remember, research chemicals are experimental chemicals that are not approved for human consumption. This is because not enough data exists currently about their effects in humans. Although some people are willing to ingest research chemicals, it is unreasonable to assume that they are in any way safe to use recreationally.
In 2001, a man was rushed to the emergency room and put into intensive care after ingesting a substance reported to be DPT. Altough he survived the experience, he reported numerous negative effects such as seizures, high heart rate, and a severe drop in blood potassium levels (Erowid).
|Ehrlich’s Reagent||Marquis Reagent|
(Info provided by DEA, 2005)
- Low doses of dipropyltryptamine in psychotherapy
- The Peak Experience Variable in DPT-Assisted Psychotherapy
- Mystical and archetypal experiences of terminal patients in DPT-assisted psychotherapy
- Psychedelic drug (DPT)-assisted psychotherapy with alcoholics: A controlled study
- Binding properties of dipropyltryptamine at the human 5-HT1a receptor
- Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at theserotonin uptake transporter and the vesicle monoamine transporter